Sensato Investors’s Novartis NVS Stock Holding History

Sensato Investors’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-40,511	Closed	-$3.05M	–	94
2017 Q4	$3.05M	Buy	+40,511	New	+$3.06M	0.38%	56

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Sensato Investors's NVS Position: Q1 2018 in Review

Sensato Investors sold out of Novartis (NVS) in Q1 2018, closing a stake of 40,511 shares — an estimated $3.05M sold.

Sensato Investors first reported a position in NVS in Q4 2017 and held it in 1 quarter. The position peaked at $3.05M in Q4 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Sensato Investors reported no remaining Novartis position as of Q1 2018 after selling out during the quarter.
Sensato Investors sold 40,511 Novartis shares in Q1 2018, an estimated $3.05M.
Sensato Investors first reported a position in Novartis in Q4 2017 and held it in 1 quarter.
Sensato Investors's Novartis position peaked at $3.05M in Q4 2017.
1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Sensato Investors's 13F filing for Q1 2018, filed 15 May 2018.